On June 1, Astera Labs fell 3.94% in pre-market trading, trading at $327.94/share, with trading volume of approximately $12.36 million.

On the news front, multiple headwinds continue to weigh on the stock. Northland Capital Markets previously downgraded Astera Labs from Outperform to Market Perform, citing elevated valuation and growing concerns that hyperscale cloud providers may cut AI infrastructure spending in 2027. According to FactSet data, the analyst consensus target price stands at $246.01, significantly below the current share price, underscoring persistent valuation pressure.

Adding to bearish sentiment, the company's President and COO recently sold approximately 399,000 shares at prices between $289.13 and $293.03, while a trust associated with a former executive disclosed plans to sell an additional 30,000 shares worth approximately $10.44 million. The concentrated insider selling has further reinforced market concerns that the stock remains overvalued relative to fundamentals, keeping shares under sustained pressure despite prior positive catalysts including the Anthropic-AWS $100 billion compute agreement and strong Q1 earnings.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)